12.01.08(a): rheumatoid arthritis/pathogenesis and clinical presentation of joint inflammation and...
DESCRIPTION
Slideshow is from the University of Michigan Medical School's M2 Musculoskeletal sequence View additional course materials on Open.Michigan: openmi.ch/med-M2MuscuTRANSCRIPT
![Page 1: 12.01.08(a): Rheumatoid Arthritis/Pathogenesis and Clinical Presentation of Joint Inflammation and Destructio](https://reader034.vdocuments.net/reader034/viewer/2022052504/554b0c44b4c9056f098b46d2/html5/thumbnails/1.jpg)
Author(s): David A. Fox, M.D., 2009 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution – Non-Commercial 3.0 License: http://creativecommons.org/licenses/by-nc/3.0/
We have reviewed this material in accordance with U.S. Copyright Law and have tried to maximize your ability to use, share, and adapt it. The citation key on the following slide provides information about how you may share and adapt this material. Copyright holders of content included in this material should contact [email protected] with any questions, corrections, or clarification regarding the use of content. For more information about how to cite these materials visit http://open.umich.edu/education/about/terms-of-use. Any medical information in this material is intended to inform and educate and is not a tool for self-diagnosis or a replacement for medical evaluation, advice, diagnosis or treatment by a healthcare professional. Please speak to your physician if you have questions about your medical condition. Viewer discretion is advised: Some medical content is graphic and may not be suitable for all viewers.
![Page 2: 12.01.08(a): Rheumatoid Arthritis/Pathogenesis and Clinical Presentation of Joint Inflammation and Destructio](https://reader034.vdocuments.net/reader034/viewer/2022052504/554b0c44b4c9056f098b46d2/html5/thumbnails/2.jpg)
Citation Key for more information see: http://open.umich.edu/wiki/CitationPolicy
Use + Share + Adapt
Make Your Own Assessment
Creative Commons – Attribution License
Creative Commons – Attribution Share Alike License
Creative Commons – Attribution Noncommercial License
Creative Commons – Attribution Noncommercial Share Alike License
GNU – Free Documentation License
Creative Commons – Zero Waiver
Public Domain – Ineligible: Works that are ineligible for copyright protection in the U.S. (17 USC § 102(b)) *laws in your jurisdiction may differ
Public Domain – Expired: Works that are no longer protected due to an expired copyright term.
Public Domain – Government: Works that are produced by the U.S. Government. (17 USC § 105)
Public Domain – Self Dedicated: Works that a copyright holder has dedicated to the public domain.
Fair Use: Use of works that is determined to be Fair consistent with the U.S. Copyright Act. (17 USC § 107) *laws in your jurisdiction may differ
Our determination DOES NOT mean that all uses of this 3rd-party content are Fair Uses and we DO NOT guarantee that your use of the content is Fair.
To use this content you should do your own independent analysis to determine whether or not your use will be Fair.
{ Content the copyright holder, author, or law permits you to use, share and adapt. }
{ Content Open.Michigan believes can be used, shared, and adapted because it is ineligible for copyright. }
{ Content Open.Michigan has used under a Fair Use determination. }
![Page 3: 12.01.08(a): Rheumatoid Arthritis/Pathogenesis and Clinical Presentation of Joint Inflammation and Destructio](https://reader034.vdocuments.net/reader034/viewer/2022052504/554b0c44b4c9056f098b46d2/html5/thumbnails/3.jpg)
Rheumatoid Arthritis/Pathogenesis and Clinical Presentation of Joint Inflammation and Destruction
M2 Musculoskeletal Sequence
Fall 2008 David A. Fox, M.D.
![Page 4: 12.01.08(a): Rheumatoid Arthritis/Pathogenesis and Clinical Presentation of Joint Inflammation and Destructio](https://reader034.vdocuments.net/reader034/viewer/2022052504/554b0c44b4c9056f098b46d2/html5/thumbnails/4.jpg)
Reading Assignment Primer on the Rheumatic Diseases, 13th edition Chapter 6A, pp 114-121 Chapter 6B, pp. 122-132 Optional in-depth reading Arthritis and Allied Conditions – A textbook of Rheumatology, WJ Koopman, Ed. Chapter 52, pp. 1089-1115, 15th Edition Learning Objectives 1. Understand how to distinguish rheumatoid arthritis (RA) from other
forms of arthritis, such as osteoarthritis. 2. Understand the main clinical features of RA in the joints. 3. Understand the major theories concerning the cause of RA. 4. Understand mechanisms of tissue destruction in the RA joint. 5. Understand the role of TNF (tumor necrosis factor) and other key
cytokines in RA.
NOTE: The lecture will include interaction with a patient who has had RA for 29 years, and demonstration of some changes that RA can cause in the joints – material that is not included in this handout. The first half hour will focus on an interview with the patient, including opportunities for the students to ask questions.
![Page 5: 12.01.08(a): Rheumatoid Arthritis/Pathogenesis and Clinical Presentation of Joint Inflammation and Destructio](https://reader034.vdocuments.net/reader034/viewer/2022052504/554b0c44b4c9056f098b46d2/html5/thumbnails/5.jpg)
Source Undetermined
![Page 6: 12.01.08(a): Rheumatoid Arthritis/Pathogenesis and Clinical Presentation of Joint Inflammation and Destructio](https://reader034.vdocuments.net/reader034/viewer/2022052504/554b0c44b4c9056f098b46d2/html5/thumbnails/6.jpg)
NB is a 71-year old woman who was diagnosed with rheumatoid arthritis in 1977, involving the hands, wrists, elbows, shoulders, feet and eventually cervical spine. Family history is notable for autoimmune disease affecting both of the patient’s daughters, one with rheumatoid arthritis and the other with systemic lupus. During the first ten years of her illness medical treatment included salicylates, non-steroidals, intramuscular gold, oral gold and prednisone. Methotrexate was first administered in 1989 and her initial visit at the University of Michigan was in 1993. Due to the rheumatoid arthritis the patient had to retire from her position as a high school English teacher.
![Page 7: 12.01.08(a): Rheumatoid Arthritis/Pathogenesis and Clinical Presentation of Joint Inflammation and Destructio](https://reader034.vdocuments.net/reader034/viewer/2022052504/554b0c44b4c9056f098b46d2/html5/thumbnails/7.jpg)
Rheumatoid Arthritis: 1987 Revised Diagnostic Criteria
Patients must have 4 of 7 criteria: ! *Morning stiffness lasting at least 1 hour ! *Simultaneous arthritis of 3 or more joints ! *Arthritis of hand joints ! *Symmetrical arthritis ! Rheumatoid nodules ! Abnormal serum rheumatoid factor ! Typical changes on PA x-ray film of hand and wrist
Adapted from Arnett FC, Edworthy SM, Bloch DA, et al: Arthritis Rheum 1988; 31:319.
* Must persist for at least 6 weeks Patients may also have another rheumatic disease so long as RA criteria are met. RA no longer to be designated classical, definite, or probable.
![Page 8: 12.01.08(a): Rheumatoid Arthritis/Pathogenesis and Clinical Presentation of Joint Inflammation and Destructio](https://reader034.vdocuments.net/reader034/viewer/2022052504/554b0c44b4c9056f098b46d2/html5/thumbnails/8.jpg)
Factors Useful for Differentiating Early RA from Osteoarthrosis (Osteoarthritis)
RA Osteoarthrosis Age of onset Usually age 20-65 Increases with age
peak incidence in 50’s Predisposing factors HLA-DR4 Trauma, obesity (OA of the
knee), congenital abnormalities (e.g., shallow acetabulum)
Symptoms, early Morning stiffness Pain increases through the day and with use
Joints involved Hands (metacarpophalangeal , Distal interphalangeal joints
proximal interphalangeal joints) (Heberden’s nodes), proximal wrists, elbows, shoulders, interphalangeal joints hips, knees, ankles, feet (Bouchard’s nodes), weight- cervical spine. The thoracic bearing joints (hips, knees), spine, lumbar spine and distal spine (any region). interphalangeal joints of the hand are almost never affected.
Physical findings Soft tissue swelling, warmth, Bony osteophytes, minimal deformities soft tissue swelling early
Radiographic findings Periarticular osteopenia, Subchondral sclerosis, marginal erosions osteophytes, cartilage loss
Laboratory findings Increased erythrocyte Normal
sedimentation rate: rheumatoid factor, anemia, thrombocytosis, hypoalbuminemia
![Page 9: 12.01.08(a): Rheumatoid Arthritis/Pathogenesis and Clinical Presentation of Joint Inflammation and Destructio](https://reader034.vdocuments.net/reader034/viewer/2022052504/554b0c44b4c9056f098b46d2/html5/thumbnails/9.jpg)
Causes of Chronic Inflammatory Polyarthritis (a partial list)
• Rheumatoid arthritis " Systemic rheumatic disease
• Systemic lupus • Scleroderma • Polymyositis • Vasculitis
" Spondylarthropathies • Ankylosing spondylitis • Reiter’s syndrome
" Psoriatic arthritis " Gout " Pseudogout " Rheumatic fever " Juvenile rheumatoid arthritis
![Page 10: 12.01.08(a): Rheumatoid Arthritis/Pathogenesis and Clinical Presentation of Joint Inflammation and Destructio](https://reader034.vdocuments.net/reader034/viewer/2022052504/554b0c44b4c9056f098b46d2/html5/thumbnails/10.jpg)
Specific Joint Involvement in Polyarthritis
Joints Involved Common With Rare In Temporomandibular Rheumatoid arthritis, juvenile Gout rheumatoid arthritis
Larynx (crico-arytenoid) Rheumatoid arthritis All other
Elbows, wrists, metacarpophalangeals Any synovitis Osteoarthritis
Distal interphalangeal Osteoarthritis, psoriatic arthritis Rheumatoid arthritis joints (hand)
Hips Osteoarthritis, rheumatoid Gout arthritis
Cervical spine Rheumatoid arthritis, juvenile Gout rheumatoid arthritis, psoriasis, osteoarthritis, spondyoarthropathies
Thoracolumbar spine Spondyloarthropathies: Gout, Ankylosing spondylitis Rheumatoid Arthritis Psoriatic arthritis Reiter’s syndrome Inflammatory bowel disease-associated arthritis
Osteoarthritis
![Page 11: 12.01.08(a): Rheumatoid Arthritis/Pathogenesis and Clinical Presentation of Joint Inflammation and Destructio](https://reader034.vdocuments.net/reader034/viewer/2022052504/554b0c44b4c9056f098b46d2/html5/thumbnails/11.jpg)
Synovial Fluid Leukocyte Count (x103)
Condition 0 1 2 4 8 16 32 64 128 PUS
Normal xxx Osteoarthritis xxxxxxxx
Rheumatoid arthritis xxxxxxxxxxxxxxxxxxxxxxxxxxxxx Juvenile rheumatoid xxxxxxxxxxxxxxxxxxxxxxxxxxxxx arthritis
Gout xxxxxxxxxxxxxxxxxxxxxx
Septic arthritis xxxxxxxxxxxxxxxxxxx
![Page 12: 12.01.08(a): Rheumatoid Arthritis/Pathogenesis and Clinical Presentation of Joint Inflammation and Destructio](https://reader034.vdocuments.net/reader034/viewer/2022052504/554b0c44b4c9056f098b46d2/html5/thumbnails/12.jpg)
Clinical Spectrum of RA
J. Cush, 2002. (All images)
![Page 13: 12.01.08(a): Rheumatoid Arthritis/Pathogenesis and Clinical Presentation of Joint Inflammation and Destructio](https://reader034.vdocuments.net/reader034/viewer/2022052504/554b0c44b4c9056f098b46d2/html5/thumbnails/13.jpg)
PIP swelling
Source Undetermined
![Page 14: 12.01.08(a): Rheumatoid Arthritis/Pathogenesis and Clinical Presentation of Joint Inflammation and Destructio](https://reader034.vdocuments.net/reader034/viewer/2022052504/554b0c44b4c9056f098b46d2/html5/thumbnails/14.jpg)
PIP nodules, MCP swelling/subluxation
Source Undetermined
![Page 15: 12.01.08(a): Rheumatoid Arthritis/Pathogenesis and Clinical Presentation of Joint Inflammation and Destructio](https://reader034.vdocuments.net/reader034/viewer/2022052504/554b0c44b4c9056f098b46d2/html5/thumbnails/15.jpg)
Boutoniere deformity of the fingers
Source Undetermined
![Page 16: 12.01.08(a): Rheumatoid Arthritis/Pathogenesis and Clinical Presentation of Joint Inflammation and Destructio](https://reader034.vdocuments.net/reader034/viewer/2022052504/554b0c44b4c9056f098b46d2/html5/thumbnails/16.jpg)
Ulnar deviation, MCPs of right hand
Source Undetermined
![Page 17: 12.01.08(a): Rheumatoid Arthritis/Pathogenesis and Clinical Presentation of Joint Inflammation and Destructio](https://reader034.vdocuments.net/reader034/viewer/2022052504/554b0c44b4c9056f098b46d2/html5/thumbnails/17.jpg)
Extensor tendon synovitis leading to rupture of extensor tendons
Source Undetermined
![Page 18: 12.01.08(a): Rheumatoid Arthritis/Pathogenesis and Clinical Presentation of Joint Inflammation and Destructio](https://reader034.vdocuments.net/reader034/viewer/2022052504/554b0c44b4c9056f098b46d2/html5/thumbnails/18.jpg)
Thenar atrophy from wrist synovitis and median nerve compression
Source Undetermined
![Page 19: 12.01.08(a): Rheumatoid Arthritis/Pathogenesis and Clinical Presentation of Joint Inflammation and Destructio](https://reader034.vdocuments.net/reader034/viewer/2022052504/554b0c44b4c9056f098b46d2/html5/thumbnails/19.jpg)
MTP deformities
Source Undetermined
![Page 20: 12.01.08(a): Rheumatoid Arthritis/Pathogenesis and Clinical Presentation of Joint Inflammation and Destructio](https://reader034.vdocuments.net/reader034/viewer/2022052504/554b0c44b4c9056f098b46d2/html5/thumbnails/20.jpg)
MTP subluxation with plantar ulceration
Source Undetermined
![Page 21: 12.01.08(a): Rheumatoid Arthritis/Pathogenesis and Clinical Presentation of Joint Inflammation and Destructio](https://reader034.vdocuments.net/reader034/viewer/2022052504/554b0c44b4c9056f098b46d2/html5/thumbnails/21.jpg)
Development of bone erosion
Source Undetermined
![Page 22: 12.01.08(a): Rheumatoid Arthritis/Pathogenesis and Clinical Presentation of Joint Inflammation and Destructio](https://reader034.vdocuments.net/reader034/viewer/2022052504/554b0c44b4c9056f098b46d2/html5/thumbnails/22.jpg)
Radiographic Evaluation of Arthritis
1. Soft tissue swelling
2. Periarticular demineralization
3. Articular erosions
4. Reactive bone formation
5. Joint narrowing
6. Joint deformity
7. Distribution of involvement
![Page 23: 12.01.08(a): Rheumatoid Arthritis/Pathogenesis and Clinical Presentation of Joint Inflammation and Destructio](https://reader034.vdocuments.net/reader034/viewer/2022052504/554b0c44b4c9056f098b46d2/html5/thumbnails/23.jpg)
Radiographic Features of Rheumatoid Arthritis and Osteoarthritis in the Hand
Rheumatoid Arthritis Radiograhic Findings Osteoarthritis
prominent, fusiform soft tissue swelling mild, focal
prominent, early periarticular demineralization not present
surface, pocketed or cystic articular erosions occasionally, cystic
minimal reactive bone formation prominent osteophytosis and subchondral sclerosis
mid to late, uniform joint narrowing early, irregular
late, subluxations an ddislocations joint deformity early, mild subluxation
wrists, metacarpophalangeal and proximal interphalangeal joints
distribution of involvement distal interphalangeal, proximal interphalangeal and 1st carpometacarpal joints
early, asymmetric and non-uniform late, symmetric and uniform
asymetric and non-uniform
![Page 24: 12.01.08(a): Rheumatoid Arthritis/Pathogenesis and Clinical Presentation of Joint Inflammation and Destructio](https://reader034.vdocuments.net/reader034/viewer/2022052504/554b0c44b4c9056f098b46d2/html5/thumbnails/24.jpg)
MTP erosions
Source Undetermined
![Page 25: 12.01.08(a): Rheumatoid Arthritis/Pathogenesis and Clinical Presentation of Joint Inflammation and Destructio](https://reader034.vdocuments.net/reader034/viewer/2022052504/554b0c44b4c9056f098b46d2/html5/thumbnails/25.jpg)
End-stage RA
Source Undetermined
![Page 26: 12.01.08(a): Rheumatoid Arthritis/Pathogenesis and Clinical Presentation of Joint Inflammation and Destructio](https://reader034.vdocuments.net/reader034/viewer/2022052504/554b0c44b4c9056f098b46d2/html5/thumbnails/26.jpg)
Source Undetermined
![Page 27: 12.01.08(a): Rheumatoid Arthritis/Pathogenesis and Clinical Presentation of Joint Inflammation and Destructio](https://reader034.vdocuments.net/reader034/viewer/2022052504/554b0c44b4c9056f098b46d2/html5/thumbnails/27.jpg)
Source Undetermined
![Page 28: 12.01.08(a): Rheumatoid Arthritis/Pathogenesis and Clinical Presentation of Joint Inflammation and Destructio](https://reader034.vdocuments.net/reader034/viewer/2022052504/554b0c44b4c9056f098b46d2/html5/thumbnails/28.jpg)
Source Undetermined
![Page 29: 12.01.08(a): Rheumatoid Arthritis/Pathogenesis and Clinical Presentation of Joint Inflammation and Destructio](https://reader034.vdocuments.net/reader034/viewer/2022052504/554b0c44b4c9056f098b46d2/html5/thumbnails/29.jpg)
Pannus eroding cartilage and bone
Source Undetermined
![Page 30: 12.01.08(a): Rheumatoid Arthritis/Pathogenesis and Clinical Presentation of Joint Inflammation and Destructio](https://reader034.vdocuments.net/reader034/viewer/2022052504/554b0c44b4c9056f098b46d2/html5/thumbnails/30.jpg)
Hypothesis for the Cause of RA
Synoviocyte transformation, synoviocyte interaction with macrophages, cartilage and bone
Cellular immune mechanisms (T cells, cytokines, monocytes
Humoral immune mechanisms (RF, immune complexes, complement)
Infection
1920 1940 1960 1980 2000
![Page 31: 12.01.08(a): Rheumatoid Arthritis/Pathogenesis and Clinical Presentation of Joint Inflammation and Destructio](https://reader034.vdocuments.net/reader034/viewer/2022052504/554b0c44b4c9056f098b46d2/html5/thumbnails/31.jpg)
Microbial Organisms Proposed as Possible Triggers for RA
Bacterial gram positive cocci mycobacteria proteus E. coli mycoplasma
Viral Epstein-Barr virus parvovirus retroviruses cytomegalovirus rubella human herpes virus 6
![Page 32: 12.01.08(a): Rheumatoid Arthritis/Pathogenesis and Clinical Presentation of Joint Inflammation and Destructio](https://reader034.vdocuments.net/reader034/viewer/2022052504/554b0c44b4c9056f098b46d2/html5/thumbnails/32.jpg)
D. Fox
![Page 33: 12.01.08(a): Rheumatoid Arthritis/Pathogenesis and Clinical Presentation of Joint Inflammation and Destructio](https://reader034.vdocuments.net/reader034/viewer/2022052504/554b0c44b4c9056f098b46d2/html5/thumbnails/33.jpg)
Genetic Susceptibility
" Familial aggregation and twin studies suggest that genetics may play a role in the development of RA
" Multiple genes involved
" In many populations (excluding most southern Europeans), approximately 80% of patients with RA share a common amino acid sequence in HLA-DR4 molecules (QKRAA) (shared epitope hypothesis)
" The presence of multiple copies of QKRAA may also predict disease severity
" Several non-MHC loci identified, all related to cellular immune responses
![Page 34: 12.01.08(a): Rheumatoid Arthritis/Pathogenesis and Clinical Presentation of Joint Inflammation and Destructio](https://reader034.vdocuments.net/reader034/viewer/2022052504/554b0c44b4c9056f098b46d2/html5/thumbnails/34.jpg)
Hypothesis for the Cause of RA
Synoviocyte transformation, synoviocyte interaction with macrophages, cartilage and bone
Cellular immune mechanisms (T cells, cytokines, monocytes
Humoral immune mechanisms (RF, immune complexes, complement)
Infection
1920 1940 1960 1980 2000
![Page 35: 12.01.08(a): Rheumatoid Arthritis/Pathogenesis and Clinical Presentation of Joint Inflammation and Destructio](https://reader034.vdocuments.net/reader034/viewer/2022052504/554b0c44b4c9056f098b46d2/html5/thumbnails/35.jpg)
Autoantibodies in Rheumatoid Arthritis
" rheumatoid factor (RF)
" anti-nuclear antibodiesanti-type II collagen
" anti-type IX collagen
" anti-cardiolipin
" anti-neutrophil cytoplasmic antibodies
" anti-keratin antibodies
" anti-perinuclear factor
" anti-calpastatin
" anti-citrullinated peptides (anti-CCP)
![Page 36: 12.01.08(a): Rheumatoid Arthritis/Pathogenesis and Clinical Presentation of Joint Inflammation and Destructio](https://reader034.vdocuments.net/reader034/viewer/2022052504/554b0c44b4c9056f098b46d2/html5/thumbnails/36.jpg)
Source Undetermined
![Page 37: 12.01.08(a): Rheumatoid Arthritis/Pathogenesis and Clinical Presentation of Joint Inflammation and Destructio](https://reader034.vdocuments.net/reader034/viewer/2022052504/554b0c44b4c9056f098b46d2/html5/thumbnails/37.jpg)
Rheumatoid Factor- Evidence for a Role in the Pathogenesis of RA
" Most patients with RA have elevated levels of rheumatoid factor
" High titers of rheumatoid factor correlate with severe articular disease and with development of extra-articular manifestations.
" Pre-existing elevations of rheumatoid factor predict subsequent development of RA.
" Rheumatoid factor production is prominent in RA synovial tissue, and such rheumatoid factors show evidence of antigen-driven affinity maturation.
" Rheumatoid factor can enhance formation of pathogenic immune complexes.
" B cells bearing surface rheumatoid factor can trap antigens contained in immune complexes and present them to primed T cells.
![Page 38: 12.01.08(a): Rheumatoid Arthritis/Pathogenesis and Clinical Presentation of Joint Inflammation and Destructio](https://reader034.vdocuments.net/reader034/viewer/2022052504/554b0c44b4c9056f098b46d2/html5/thumbnails/38.jpg)
IgM Rheumatoid Factor Rheumatoid Factor Frequently Present Usually Absent
Rheumatic diseases Osteoarthritis
Ankylosing spondylitis Rheumatoid arthritis Gout Sjogren’s syndrome (with or with arthritis) Chondrocalcinosis Systemic lupus erythematosus Suppurative arthritis Progressive systemic sclerosis Psoriatic arthritis Polymyositis/dermatomyositis Enteropathic arthritis Cryoglobulinemia Reiter’s syndrome
Infectious diseases IgM Rheumatoid Factor Frequently Present
Bacterial endocarditis Tuberculosis Noninfectious diseases Syphillis Infectious hepatitis Normal aged individuals Leprosy Diffuse interstitial pulmonary fibrosis
Schistosomiasis Cirrhosis of liver, chronic active hepatitis
Sarcoidosis Waldenstrom’s macroglobulinemia
Occurrence of Rheumatoid Factor in Various Diseases
![Page 39: 12.01.08(a): Rheumatoid Arthritis/Pathogenesis and Clinical Presentation of Joint Inflammation and Destructio](https://reader034.vdocuments.net/reader034/viewer/2022052504/554b0c44b4c9056f098b46d2/html5/thumbnails/39.jpg)
Anti-CCP and RA
" CCP = cyclic citrullinated peptides
" Arginine citrulline
" PADI = peptidyl arginine deiminase
" Citrullinated proteins abundant in inflamed synovium
" Smoking citrullination of proteins in the lung
PADI
![Page 40: 12.01.08(a): Rheumatoid Arthritis/Pathogenesis and Clinical Presentation of Joint Inflammation and Destructio](https://reader034.vdocuments.net/reader034/viewer/2022052504/554b0c44b4c9056f098b46d2/html5/thumbnails/40.jpg)
Risk Factors for RA
" Genetic " MHC Class II alleles
" Multiple other genes
" Environmental " ? infection
" smoking
![Page 41: 12.01.08(a): Rheumatoid Arthritis/Pathogenesis and Clinical Presentation of Joint Inflammation and Destructio](https://reader034.vdocuments.net/reader034/viewer/2022052504/554b0c44b4c9056f098b46d2/html5/thumbnails/41.jpg)
Never smokers Current smokers
Relative Risk of seropositive RA in Individuals with Different SE Genotype
Double SE gene
No SE genes Single SE gene
Never smokers
Current smokers
RR
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
Source: Padyukov, Silva, Stolt, Alfredsson, Klareskog; A&R 2004;50:3085-92 D. Fox
![Page 42: 12.01.08(a): Rheumatoid Arthritis/Pathogenesis and Clinical Presentation of Joint Inflammation and Destructio](https://reader034.vdocuments.net/reader034/viewer/2022052504/554b0c44b4c9056f098b46d2/html5/thumbnails/42.jpg)
Predicting RA Before its Clinical Onset
" Genes
" Smoking
" Anti-CCP
![Page 43: 12.01.08(a): Rheumatoid Arthritis/Pathogenesis and Clinical Presentation of Joint Inflammation and Destructio](https://reader034.vdocuments.net/reader034/viewer/2022052504/554b0c44b4c9056f098b46d2/html5/thumbnails/43.jpg)
Hypothesis for the Cause of RA
Synoviocyte transformation, synoviocyte interaction with macrophages, cartilage and bone
Cellular immune mechanisms (T cells, cytokines, monocytes
Humoral immune mechanisms (RF, immune complexes, complement)
Infection
1920 1940 1960 1980 2000
![Page 44: 12.01.08(a): Rheumatoid Arthritis/Pathogenesis and Clinical Presentation of Joint Inflammation and Destructio](https://reader034.vdocuments.net/reader034/viewer/2022052504/554b0c44b4c9056f098b46d2/html5/thumbnails/44.jpg)
Evidence for a Central Role for T cells in RA
1. Large numbers of T cells an antigen-presenting cells are present in synovial tissue and fluid.
2. Synovial T cells express activation and memory makers.
3. T cell subsets and possibly clonal T cell populations, accumulate in RA joints in a non-random manner.
4. RA is associated with specific MHC class II alleles (DR and/or DQ).
5. RA is associated with a polymorphism at PTPN22, a tyrosine phosphatase that regulates signaling through the T cell receptor.
6. T cell-directed therapeutic interventions may be effective in RA, and are clearly effective in animal models.
7. T cell cytokines, such as IL-17, that are present in RA joints, mediate biologic effects highly relevant to the pathogenesis of joint inflammation and damage.
![Page 45: 12.01.08(a): Rheumatoid Arthritis/Pathogenesis and Clinical Presentation of Joint Inflammation and Destructio](https://reader034.vdocuments.net/reader034/viewer/2022052504/554b0c44b4c9056f098b46d2/html5/thumbnails/45.jpg)
Proposed Antigenic Targets for T cells in RA
Microbial antigens Autoantigens Superantigens, such as Collagen (Type II and other types) staphylococcal toxins gp39 Epstein-Barr virus antigens Cartilage link protein Heat shock proteins Cartilage proteoglycan Mycobacterial antigens 205kDa synovial fluid antigens Parvovirus antigens Immunoglobulin binding protein (BiP) Peptidoglycan from Heat shock proteins gram+ bacteria Class II MHC (shared epitope)
IgG (Fc portion) RA33 (heterogeneous nuclear ribonucleoprotein A2) Filaggrin Glycosaminoglycans
![Page 46: 12.01.08(a): Rheumatoid Arthritis/Pathogenesis and Clinical Presentation of Joint Inflammation and Destructio](https://reader034.vdocuments.net/reader034/viewer/2022052504/554b0c44b4c9056f098b46d2/html5/thumbnails/46.jpg)
RA a Th-17 disease?
" IL-17 is found in abundance in arthritic joints and serum
" Administration of IL-17 worsens CIA (collagen-induced arthritis, an animal model of RA)
" IL-17 R and IL-17 knockout mice develop less severe arthritis
" Neutralizing antibody to IL-17 reduces severity of CIA
" IL-23 deficient mice develop less severe arthritis
" Recent human study shows IL-17 and TNF mRNA in RA synovium predict aggressive disease
![Page 47: 12.01.08(a): Rheumatoid Arthritis/Pathogenesis and Clinical Presentation of Joint Inflammation and Destructio](https://reader034.vdocuments.net/reader034/viewer/2022052504/554b0c44b4c9056f098b46d2/html5/thumbnails/47.jpg)
IL-17
" 17 kD cytokine
" Secreted by activated and memory T cells, recently defined as a distinct Th subset
" Six isoforms, termed IL-17 A-F
" “IL-17” = IL-17A
" Induced by IL-6 and TGFβ
![Page 48: 12.01.08(a): Rheumatoid Arthritis/Pathogenesis and Clinical Presentation of Joint Inflammation and Destructio](https://reader034.vdocuments.net/reader034/viewer/2022052504/554b0c44b4c9056f098b46d2/html5/thumbnails/48.jpg)
IL-23 and IL-17
" IL-23 is a cytokine made by APC’s
" IL-23 and IL-12 are both heterodimers
" IL-23 and IL-12 share an identical p40 subunit
" IL-23 also contains a p19 subunit, IL-12 a p35 subunit
" IL-12 induces gamma-interferon
" IL-23 induces IL-17
" Co-stimulatory signals can also induce IL-17 when TCR is triggered
![Page 49: 12.01.08(a): Rheumatoid Arthritis/Pathogenesis and Clinical Presentation of Joint Inflammation and Destructio](https://reader034.vdocuments.net/reader034/viewer/2022052504/554b0c44b4c9056f098b46d2/html5/thumbnails/49.jpg)
T-Helper Cell Differentiation
Christina M Tato an dJohn J. O’Shea, Nature 441, 11 May 2006
![Page 50: 12.01.08(a): Rheumatoid Arthritis/Pathogenesis and Clinical Presentation of Joint Inflammation and Destructio](https://reader034.vdocuments.net/reader034/viewer/2022052504/554b0c44b4c9056f098b46d2/html5/thumbnails/50.jpg)
Hypothesis for the Cause of RA
Synoviocyte transformation, synoviocyte interaction with macrophages, cartilage and bone
Cellular immune mechanisms (T cells, cytokines, monocytes
Humoral immune mechanisms (RF, immune complexes, complement)
Infection
1920 1940 1960 1980 2000
![Page 51: 12.01.08(a): Rheumatoid Arthritis/Pathogenesis and Clinical Presentation of Joint Inflammation and Destructio](https://reader034.vdocuments.net/reader034/viewer/2022052504/554b0c44b4c9056f098b46d2/html5/thumbnails/51.jpg)
Image of cell-cell interactions in
rheumatoid arthritis removed
![Page 52: 12.01.08(a): Rheumatoid Arthritis/Pathogenesis and Clinical Presentation of Joint Inflammation and Destructio](https://reader034.vdocuments.net/reader034/viewer/2022052504/554b0c44b4c9056f098b46d2/html5/thumbnails/52.jpg)
Cell-cell Interactions in RA Synovium
Leukocyte-endothelial
T cell-dendritic cell
T cell-macrophage
Macrophage-fibroblast
T cell-fibroblast
B cell-fibroblast
![Page 53: 12.01.08(a): Rheumatoid Arthritis/Pathogenesis and Clinical Presentation of Joint Inflammation and Destructio](https://reader034.vdocuments.net/reader034/viewer/2022052504/554b0c44b4c9056f098b46d2/html5/thumbnails/53.jpg)
Source Undetermined
![Page 54: 12.01.08(a): Rheumatoid Arthritis/Pathogenesis and Clinical Presentation of Joint Inflammation and Destructio](https://reader034.vdocuments.net/reader034/viewer/2022052504/554b0c44b4c9056f098b46d2/html5/thumbnails/54.jpg)
Source Undetermined
![Page 55: 12.01.08(a): Rheumatoid Arthritis/Pathogenesis and Clinical Presentation of Joint Inflammation and Destructio](https://reader034.vdocuments.net/reader034/viewer/2022052504/554b0c44b4c9056f098b46d2/html5/thumbnails/55.jpg)
Cytokines " Intercellular messenger molecules " Synthesis
• Heterogeneity of cell types • Inducible
" Effects • Primarily local (systemic when produced in
abundance) • Mediated through
" Cell-associated receptors on target cells " Intracellular signaling and gene transcription
" Regulation controlled at many steps " Message induction " Soluble receptors " Soluble receptor antagonists
![Page 56: 12.01.08(a): Rheumatoid Arthritis/Pathogenesis and Clinical Presentation of Joint Inflammation and Destructio](https://reader034.vdocuments.net/reader034/viewer/2022052504/554b0c44b4c9056f098b46d2/html5/thumbnails/56.jpg)
Role of Cytokines and Cytokine Inhibitors in Chronic Inflammation
TNF!
Pro-inflammatory Anti-inflammatory
IL-1
Soluble TNF Receptor IL-10
IL-1 Receptor
Antagonist
Adapted with permission from Feldmann M et al. Cell. 1996:85:307-310.
![Page 57: 12.01.08(a): Rheumatoid Arthritis/Pathogenesis and Clinical Presentation of Joint Inflammation and Destructio](https://reader034.vdocuments.net/reader034/viewer/2022052504/554b0c44b4c9056f098b46d2/html5/thumbnails/57.jpg)
Synthesis and Actions of TNF
Macrophage or activated T-cell
TNF!"
TNF !receptor"
Induction of mediators"
Target cell"
Source Undetermined
![Page 58: 12.01.08(a): Rheumatoid Arthritis/Pathogenesis and Clinical Presentation of Joint Inflammation and Destructio](https://reader034.vdocuments.net/reader034/viewer/2022052504/554b0c44b4c9056f098b46d2/html5/thumbnails/58.jpg)
Key Actions Attributed to TNF
TNF
Macrophages
Endothelium
Hepatocytes
Synoviocytes
# Pro-inflammatory cytokines # chemokines
# Adhesion molecules
# Acute phase response
# Metalloproteinase synthesis
# Vascular endothelial growth factor (VEGF)
Articular cartilage
degradation
Increased CRP in serum
Increased angiogenesis
Increased cell infiltration
Increased inflammation
Osteoclast Progenitors # RANKL expression Bone erosions
D. Fox
![Page 59: 12.01.08(a): Rheumatoid Arthritis/Pathogenesis and Clinical Presentation of Joint Inflammation and Destructio](https://reader034.vdocuments.net/reader034/viewer/2022052504/554b0c44b4c9056f098b46d2/html5/thumbnails/59.jpg)
activates IL-1
attacks cartilage Matrix
metalloproteases prostaglandin E2 IL-6
activates
secretes
Synovial Fibroblast
Monocyte
secretes
ODF Osteoclast Monocyte
Helps stimulate migration through endothelium into synovial tissue
elaborates
TNF Endothelial Cell
Surface Adhesion Molecules T-cell
Adherence of T-cells and monocytes from circulation
activates
activates activates
secretes IL-8
Source Undetermined
![Page 60: 12.01.08(a): Rheumatoid Arthritis/Pathogenesis and Clinical Presentation of Joint Inflammation and Destructio](https://reader034.vdocuments.net/reader034/viewer/2022052504/554b0c44b4c9056f098b46d2/html5/thumbnails/60.jpg)
Actions of IL-1 and Endogenous IL-1Ra
Source of original image: Dinarello CA. N Engl J Med. 2000;343:733.
Image of IL-1 interactions
removed
![Page 61: 12.01.08(a): Rheumatoid Arthritis/Pathogenesis and Clinical Presentation of Joint Inflammation and Destructio](https://reader034.vdocuments.net/reader034/viewer/2022052504/554b0c44b4c9056f098b46d2/html5/thumbnails/61.jpg)
Role of Interleukin-1 in RA
" Pro-inflammatory cytokine
" Triggers production of other proinflammatory cytokines, including TNF
" Causes T cell/neutrophil accumulation in synovium by inducing expression of endothelial adhesion molecules
" Stimulates production of collagenase and stromelysin
" Stimulates osteoclast differentiation through intermediary TNF family cytokine, RANKL
Source: Bresnihan and Cunnane. Rheum Dis Clin North Am. 1998;24:615-628.
![Page 62: 12.01.08(a): Rheumatoid Arthritis/Pathogenesis and Clinical Presentation of Joint Inflammation and Destructio](https://reader034.vdocuments.net/reader034/viewer/2022052504/554b0c44b4c9056f098b46d2/html5/thumbnails/62.jpg)
TNF and IL!1 Play a Critical Role in Osteoclast Differentiation
Cells of monocytes/ macrophage lineages
CTR (-) TRAP (-)
Prefusion osteoclasts
(pOCs)
CTR (+) TRAP (+)
Multinucleated osteoclasts
CTR (+)
TRAP (+)
Ruffled border (-)
Activated osteoclasts
CTR (+)
TRAP (+)
Ruffled border (+)
CFU-M
Proliferation Differentiation Survival & Fusion Activation
TNF
M-CSF RANKL IL-1
TNF
M-CSF +
RANKL
IL-1 M-CSF
D. Fox
![Page 63: 12.01.08(a): Rheumatoid Arthritis/Pathogenesis and Clinical Presentation of Joint Inflammation and Destructio](https://reader034.vdocuments.net/reader034/viewer/2022052504/554b0c44b4c9056f098b46d2/html5/thumbnails/63.jpg)
0 2 4 6 8
10
High Low High
Low
RANKL
Rad
iogr
aphi
c pr
ogre
ssio
n (S
harp
uni
ts/
year
)
RANKL:OPG and the Rate of Progression of Joint Destruction in RA
• RANKL promotes joint destruction
• OPG ameliorates RANKL-induced destruction of joints
• The RANKL:OPG ratio correlates well with the rate of joint destruction
• In RA osteoclasts destroy bone while synovial fibroblasts destroy cartilage
Geusens P, et al. Arthritis Rheum. 2003;48(suppl):5458 [Abstract 1145].
![Page 64: 12.01.08(a): Rheumatoid Arthritis/Pathogenesis and Clinical Presentation of Joint Inflammation and Destructio](https://reader034.vdocuments.net/reader034/viewer/2022052504/554b0c44b4c9056f098b46d2/html5/thumbnails/64.jpg)
Synovial Synovial Macrophages Macrophages
T and/or T and/or Cytokine cells Fibroblasts cells Fibroblasts Other
IL-1β + ++ + + osteoclast
TNF! + ++ + + endothelium
IL-6 +/- + + - hepatocyte,
chondrocyte
IL-8 +/- + +/- - neutrophil
IL-15 - + + - -
IL-17 + - - + -
Role of Cytokines in Rheumatoid Arthritis Synovium Producing
Cells Target Cells
![Page 65: 12.01.08(a): Rheumatoid Arthritis/Pathogenesis and Clinical Presentation of Joint Inflammation and Destructio](https://reader034.vdocuments.net/reader034/viewer/2022052504/554b0c44b4c9056f098b46d2/html5/thumbnails/65.jpg)
Source Undetermined Source Undetermined
![Page 66: 12.01.08(a): Rheumatoid Arthritis/Pathogenesis and Clinical Presentation of Joint Inflammation and Destructio](https://reader034.vdocuments.net/reader034/viewer/2022052504/554b0c44b4c9056f098b46d2/html5/thumbnails/66.jpg)
Slide 5: Source Undetermined Slide 12: J. Cush, 2002. (All images) Slide 13: Source Undetermined Slide 14: Source Undetermined Slide 15: Source Undetermined Slide 16: Source Undetermined Slide 17: Source Undetermined Slide 18: Source Undetermined Slide 19: Source Undetermined Slide 20: Source Undetermined Slide 21: Source Undetermined Slide 24: Source Undetermined Slide 25: Source Undetermined Slide 26: Source Undetermined Slide 27: Source Undetermined Slide 28: Source Undetermined Slide 29: Source Undetermined Slide 32: David Fox Slide 36: Source Undetermined Slide 41: David Fox Slide 49: Christina M Tato an dJohn J. O’Shea, Nature 441, 11 May 2006 Slide 53: Source Undetermined Slide 54: Source Undetermined Slide 56: Adapted with permission from Feldmann M et al. Cell. 1996:85:307-310. Slide 57: Source Undetermined Slide 58: David Fox Slide 59: Source Undetermined Slide 62: David Fox Slide 63: Geusens P, et al. Arthritis Rheum. 2003;48(suppl):5458 [Abstract 1145]. Slide 65: Sources Undetermined
Additional Source Information for more information see: http://open.umich.edu/wiki/CitationPolicy